Radiomics and artificial intelligence landscape for (18F)FDG PET/CT in multiple myeloma

[18F]FDG PET/CT is a powerful imaging modality of high performance in multiple myeloma (MM) and is considered the appropriate method for assessing treatment response in this disease. On the other hand, due to the heterogeneous and sometimes complex patterns of bone marrow infiltration in MM, the int...

Full description

Saved in:
Bibliographic Details
Main Authors: Sachpekidis, Christos (Author) , Goldschmidt, Hartmut (Author) , Edenbrandt, Lars (Author) , Dimitrakopoulou-Strauss, Antonia (Author)
Format: Article (Journal)
Language:English
Published: May 2025
In: Seminars in nuclear medicine
Year: 2025, Volume: 55, Issue: 3, Pages: 387-395
ISSN:1558-4623
DOI:10.1053/j.semnuclmed.2024.11.005
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1053/j.semnuclmed.2024.11.005
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0001299824001119
Get full text
Author Notes:Christos Sachpekidis, MD, Hartmut Goldschmidt, MD, Lars Edenbrandt, MD, and Antonia Dimitrakopoulou-Strauss, MD
Description
Summary:[18F]FDG PET/CT is a powerful imaging modality of high performance in multiple myeloma (MM) and is considered the appropriate method for assessing treatment response in this disease. On the other hand, due to the heterogeneous and sometimes complex patterns of bone marrow infiltration in MM, the interpretation of PET/CT can be particularly challenging, hampering interobserver reproducibility and limiting the diagnostic and prognostic ability of the modality. Although many approaches have been developed to address the issue of standardization, none can yet be considered a standard method for interpretation or objective quantification of PET/CT. Therefore, advanced diagnostic quantification approaches are needed to support and potentially guide the management of MM. In recent years, radiomics has emerged as an innovative method for high-throughput mining of image-derived features for clinical decision making, which may be particularly helpful in oncology. In addition, machine learning and deep learning, both subfields of artificial intelligence (AI) closely related to the radiomics process, have been increasingly applied to automated image analysis, offering new possibilities for a standardized evaluation of imaging modalities such as CT, PET/CT and MRI in oncology. In line with this, the initial but steadily growing literature on the application of radiomics and AI-based methods in the field of [18F]FDG PET/CT in MM has already yielded encouraging results, offering a potentially reliable tool towards optimization and standardization of interpretation in this disease. The main results of these studies are presented in this review.
Item Description:Im Titel steht 18F in eckiger Klammer, 18 ist dabei hochgestellt
Gesehen am 19.11.2025
Physical Description:Online Resource
ISSN:1558-4623
DOI:10.1053/j.semnuclmed.2024.11.005